Corgentech, Inc. (CGTK) Changes Name To Anesiva To Reflect Focus On Robust Pipeline Of Pain Therapeutics
6/22/2006 2:53:58 PM
More...
|
Corgentech, Inc. (CGTK) Secures $30 Million Committed Equity Financing Facility
6/20/2006 12:13:00 PM
More...
|
Corgentech, Inc. (CGTK) Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries; Shares Up
6/14/2006 2:05:44 PM
More...
|
Corgentech, Inc. (CGTK) To Present At Pacific Growth Equities Life Sciences Growth Conference And Needham & Company Fifth Annual Biotechnology And Medical Technology Conference
6/7/2006 11:18:48 AM
More...
|
Corgentech, Inc. (CGTK) Announces Appointment Of K. Peony Yu As Vice President, Clinical Research And Michael Leong As Director, Clinical Research
6/6/2006 11:42:52 AM
More...
|
Corgentech, Inc. (CGTK) Announces Appointment Of Susan Kramer As Vice President Of Preclinical Development
5/30/2006 10:34:24 AM
More...
|
Corgentech, Inc. (CGTK) To Host Webcast Conference Call On Wednesday, May 24, 2006
5/22/2006 2:21:20 PM
More...
|
Corgentech, Inc. (CGTK) Announces Scientific Presentation Of Pivotal Phase 3 Data Demonstrating Significant Pain Reduction Associated With Fast-Acting, Needlefree Local Anesthetic In Children
5/18/2006 10:25:22 AM
More...
|
Corgentech, Inc. (CGTK) Announces First Quarter 2006 Financial Results
5/5/2006 10:54:43 AM
More...
|
Corgentech, Inc. (CGTK) Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief Of Pain And Improved Function In Elbow Tendonitis
5/4/2006 10:24:49 AM
More...
|
|